Scarica l'app Stockscreener
70.83
1.44%
0.935
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$69.90
Aprire:
$70.21
Volume 24 ore:
103.65K
Relative Volume:
0.30
Capitalizzazione di mercato:
$2.47B
Reddito:
-
Utile/perdita netta:
$-91.00M
Rapporto P/E:
-19.30
EPS:
-3.67
Flusso di cassa netto:
$-74.38M
1 W Prestazione:
+2.35%
1M Prestazione:
+18.53%
6M Prestazione:
+83.08%
1 anno Prestazione:
+48.49%
Intervallo 1D:
$69.50
$71.23
Intervallo di 1 settimana:
$67.22
$72.68
Portata 52W:
$30.82
$72.68
Disc Medicine Inc Stock (IRON) Company Profile
Nome
Disc Medicine Inc
Settore
Industria
Telefono
(617) 674-9274
Indirizzo
321 ARSENAL STREET, SUITE 101, WATERTOWN
Confronta IRON con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
71.03 | 2.43B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.02 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.17 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
551.91 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
808.23 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.09 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-21 | Iniziato | Truist | Buy |
| 2025-07-03 | Ripresa | Morgan Stanley | Overweight |
| 2025-06-11 | Ripresa | Raymond James | Strong Buy |
| 2025-02-27 | Iniziato | TD Cowen | Buy |
| 2024-11-05 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | Iniziato | Jefferies | Buy |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-08-22 | Iniziato | Wells Fargo | Overweight |
| 2024-04-01 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | Iniziato | H.C. Wainwright | Buy |
| 2023-05-17 | Iniziato | Raymond James | Outperform |
| 2023-04-28 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-04-21 | Iniziato | Stifel | Buy |
| 2023-04-20 | Iniziato | Morgan Stanley | Overweight |
| 2023-03-23 | Iniziato | BMO Capital Markets | Outperform |
| 2023-02-28 | Iniziato | SVB Securities | Outperform |
Mostra tutto
Disc Medicine Inc Borsa (IRON) Ultime notizie
Is Disc Medicine Inc. stock trading near support levelsEarnings Beat & Safe Entry Zone Identification - newser.com
What MACD and RSI say about Disc Medicine Inc.July 2025 Volume & High Accuracy Swing Entry Alerts - newser.com
Can Disc Medicine Inc. stock weather global recession2025 Investor Takeaways & Weekly High Momentum Picks - newser.com
Disc Medicine (NASDAQ:IRON) Director Kevin Bitterman Sells 71,961 Shares - MarketBeat
Price action breakdown for Disc Medicine Inc.Weekly Stock Summary & High Accuracy Investment Entry Signals - newser.com
Tick level data insight on Disc Medicine Inc. volatilityPortfolio Value Summary & Daily Entry Point Alerts - newser.com
Real time social sentiment graph for Disc Medicine Inc.July 2025 Review & Real-Time Market Sentiment Alerts - newser.com
Disc Medicine's (IRON) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Bitterman Kevin, director at Disc Medicine, sells $6.3m in shares - Investing.com Canada
Building trade automation scripts for Disc Medicine Inc.July 2025 PreEarnings & Verified Swing Trading Watchlists - newser.com
Using RSI to spot recovery in Disc Medicine Inc.Quarterly Trade Summary & Weekly High Return Stock Opportunities - newser.com
Visual trend scoring systems applied to Disc Medicine Inc.2025 Geopolitical Influence & Detailed Earnings Play Alerts - newser.com
Momentum divergence signals in Disc Medicine Inc. chartTrade Analysis Summary & Reliable Price Breakout Alerts - newser.com
Real time pattern detection on Disc Medicine Inc. stockDip Buying & Reliable Entry Point Alerts - newser.com
Quantitative breakdown of Disc Medicine Inc. recent moveQuarterly Earnings Summary & Daily Oversold Bounce Ideas - newser.com
Disc Medicine (NASDAQ:IRON) Sets New 52-Week HighTime to Buy? - MarketBeat
Disc Medicine stock hits 52-week high at 69.38 USD By Investing.com - Investing.com Nigeria
Disc Medicine director Mona Ashiya resigns, board size reduced to eight - Investing.com
Disc Medicine Board Member Mona Ashiya Resigns - TipRanks
Disc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Disc Medicine stock hits 52-week high at 69.38 USD - Investing.com
Identifying reversal signals in Disc Medicine Inc.Market Trend Summary & Risk Controlled Daily Trade Plans - newser.com
Is Disc Medicine Inc. stock cheap at current valuationPortfolio Gains Summary & Safe Entry Momentum Stock Tips - newser.com
Developing predictive dashboards with Disc Medicine Inc. data2025 Volume Leaders & Advanced Swing Trade Entry Alerts - newser.com
Is Disc Medicine Inc. showing signs of accumulation2025 Institutional Moves & Fast Exit and Entry Strategy Plans - newser.com
Disc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Is a relief rally coming for Disc Medicine Inc. holdersEarnings Miss & Stock Portfolio Risk Management - newser.com
What momentum shifts mean for Disc Medicine Inc.Weekly Trade Recap & AI Based Buy/Sell Signal Reports - newser.com
Will Disc Medicine Inc. stock recover after recent dropEarnings Growth Summary & Daily Technical Forecast Reports - newser.com
Should you wait for a breakout in Disc Medicine Inc.2025 Market Outlook & Expert Curated Trade Setups - newser.com
Analyzing Disc Medicine Inc. with risk reward ratio charts2025 Earnings Impact & Low Volatility Stock Recommendations - newser.com
A Fresh Look at Disc Medicine’s Valuation After Bitopertin NDA Submission and Positive Phase 2 Data - Yahoo Finance
Disc Medicine Announces Submission of New Drug Application (NDA) to US FDA for Accelerated Approval of Bitopertin for Patients with Erythropoietic Protoporphyria (EPP) - Sahm
Disc MedicineBiotech Stock On The Move With Multiple Near-Term Catalysts - RTTNews
Disc Medicine (NASDAQ:IRON) Sets New 1-Year HighHere's Why - MarketBeat
Disc Medicine submits NDA for bitopertin in erythropoietic porphyria By Investing.com - Investing.com Nigeria
Disc Medicine Announces Submission of New Drug Application - GlobeNewswire
Disc Medicine Announces Submission Of NDA For Bitopertin - Nasdaq
Disc Medicine Submits New Drug Application to FDA for Bitopertin to Treat Patients With Erythropoietic Protoporphyria - MarketScreener
Disc Medicine submits NDA for bitopertin in erythropoietic porphyria - Investing.com
Disc Medicine Inc Azioni (IRON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Disc Medicine Inc Azioni (IRON) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Bitterman Kevin | Director |
Oct 07 '25 |
Sale |
68.38 |
18,039 |
1,233,493 |
572,582 |
0.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):